Frontlight ResearchEarly access
Trial site
Little Rock, Arkansas
- 6closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Parkinson disease3 trials
- Epilepsy2 trials
- Schizophrenia1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Status
- Completed5 trials
- Terminated1 trial
- Lead sponsor
- AbbVie6 trials
Closed trials
Completed
A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia
Completed
Terminated
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026